Tedaviye dirençli alerjik rinitin psikiyatrik analizi ve antidepresan kullanımı etkilerinin değerlendirilmesi

Abstract

Objective: We evaluated the incidence of psychiatric disorders in patients with allergic rhinitis (AR) and assessed the effects of the use of antidepressants on symptoms when they are included in the treatment regimen of patients with AR who are resistant to AR treatment.
Methods: A total of 49 patients who were resistant to the treatment for AR and who did not accept the option of immunotherapy were included in the study. Thirty-eight of the 40 patients were advised to take the antidepressant sertraline; however, only 21 of them agreed to use the medication while 17 of them refused. The 21 patients who agreed to begin the antidepressant were also advised to undergo AR treatment with desloratadine once per day and intranasal mometasone furoate once per day (Group 1). The patients who refused to use the antidepressant were advised to begin the AR treatment (Group 2). Symptom scoring for AR was again performed for all patients 6 weeks after treatment. The Psychological Symptom Checklist-90 (SCL-90), Beck Depression Inventory (BDI), and State-Trait Anxiety Inventory (STAI TX I and TX
II) were performed on the patients in the company of a psychiatrist.
Results: The post-treatment nasal and non-nasal symptom scores in Group 1 were significantly better than the pretreatment scores for any of the seven symptoms (p=0.000). No significant correlation was found between the AR symptom scores and the average SCL-90 general symptom score, the SCL-90 subscale scores, the total BDI scores, and the STAI scores (p>0.05).
Conclusion: This study suggests that the use of antidepressants diminishes the allergic symptoms in patients with treatment-resistant AR since psychosomatic factor is of great importance in the patient population of AR.

Keywords

• Psikiyatrik bozukluklar,alerjik rinit,antidepresan,Psychiatric disorders,allergic rhinitis,antidepressant

References

1. 1. Wright AL, Holberg CJ, Martinez FD, Halonen M, Morgan W, Taussig LM. Epidemiology of physician-diagnosed allergic rhinitis in childhood. Pediatrics 1994;94:895–901.
2. 2. Ercan I, Cakir B, Baflak T, et al. Effects of topical application of methotrexate on nasal mucosa in rats: a preclinical assessment study. Otolaryngol Head Neck Surg 2006;134:751-5.
3. 3. Passàli D, Lauriello M, Mezzedimi C, Passàli GC, Bellussi L. Natural history of allergic rhinitis. A review. Clin Appl Immunol Rev 2001;1:207–16.
4. 4. Bell IR, Jasnoski ML, Kagan J, King DS. Is allergic rhinitis more frequent in young adults with extreme shyness? A preliminary survey. Psychosom Med 1990;52:517–25.
5. 5. Bousquet, J, Bullinger, M, Fayol, C, Marquis P, Valentin B, Burtin B. Assessment of quality of life in patients with perennial allergic rhinitis with the French version of the SF-36 Health Status Questionnaire. J Allergy Clin Immunol 1994;94:182–8.
6. 6. Kremer B, Klimek L, Bullinger M, Mösges R. Generic or diseasespecific quality of life scales to characterize health status in allergic rhinitis? Allergy 2001;56:957–63.
7. 7. Ozmen M, Ozdemir A. Allergic rhinitis and psychological problems. Turkiye Klinikleri Journal of Internal Medical Sciences 2006;2:23–8.
8. 8. Gauci M, King MG, Saxarra H, Tulloch BJ, Husband AJ. A Minnesota Multiphasic Personality Inventory profile of women with allergic rhinitis. Psychosom Med 1993;55:533–40.

9. 9. Michel FB. Psychology of the allergic patients. Allergy 1994;49(18 Suppl):28–30.
10. 10. Wright RJ, Cohen RT, Cohen S. The impact of stress on the development and expression of atopy. Curr Opin Allergy Clin Immunol 2005;5:23–9.
11. 11. Cohen N. Norman Cousins Lecture. The uses and abuses of psychoneuroimmunology: a global overview. Brain Behav Immun 2006;20:99–112.
12. 12. Hashizume H, Takigawa M. Anxiety in allergy and atopic dermatitis. Curr Opin Allergy Clin Immunol 2006,6:335–9.
13. 13. Chida Y, Hamer M, Steptoe A. A bidirectional relationship between psychosocial factors and atopic disorders: a systematic review and meta-analysis. Psychosom Med 2008;70:102–16.
14. 14. Slattery MJ, Essex MJ. Specificity in the association of anxiety, depression, and atopic disorders in a community sample of adolescents. J Psychiatr Res 2011;45:788–95.
15. 15. Lv X, Xi L, Han D, Zhang L. Evaluation of the psychological status in seasonal allergic rhinitis patients. ORL J Otorhinolaryngol Relat Spec 2010;72:84–90.
16. 16. Wamboldt MZ, Hewitt JK, Schmitz S, et al. Familial association between allergic disorders and depression in Finnish twins. Am J Med Genet 2000;96:146–53.
17. 17. Sugarman AA, Southern L, Curran JF. A study of antibody levels in alcoholic, depressive and schizophrenic patients. Ann Allerg 1982; 48:16671.
18. 18. Hurwitz EL, Morganstern H. Cross-sectional associations of asthma, hay fever, and other allergies with major depression and lowback pain among adults aged 20–39 years in the United States. Am J Epidemiol 1999;150:1107–16. 19. Williams K, Bienenstock J, Perdue MH. The role of psychological and neurological factors in allergic reactions. ACI News 1992;4: 77–85.
19. 20. Tønnesen P, Hindberg I, Schaffalitzky de Muckadell OB, Mygind N. Effect of nasal allergen challenge on serotonin, substance P and vasoactive intestinal peptide in plasma and nasal secretions. Allergy 1988;43:310–7.
20. 21. Maes M. A review of the acute phase response in major depression. Rev Neurosci 1993;4:407–16.
21. 22. American Psychiatric Association. The dexamethasone suppression test: an overview of its current status in psychiatry. The APA Task Force on Laboratory Tests in Psychiatry. Am J Psychiatry 1987;144:1253–62.
22. 23. Marshall PS, O’Hara C, Steinberg P. Effects of seasonal allergic rhinitis on selected cognitive abilities. Ann Allergy Asthma Immunol 2000;84:403–10.
23. 24. Marshall PS, O’Hara C, Steinberg P. Effects of seasonal allergic rhinitis on fatigue levels and mood. Psychosom Med 2002;64:684– 91.
24. 25. Tonelli LH, Holmes A, Postolache TT. Intranasal immune challenge induces sex-dependent depressive-like behaviors and cytokine expression in the brain. Neuropsychopharmacology 2008;33:1038–48.
25. 26. Kiecolt-Glaser JK, Heffner KL, Glaser R, et al. How stress and anxiety can alter immediate and late-phase skin test responses in allergic rhinitis. Psychoneuroendocrinology 2009;34:670–80.
26. 27. Cuffel B, Wamboldt M, Borish L, Kennedy S, Crystal-Peters J. Economic consequences of comorbid depression, anxiety, and allergic rhinitis. Psychosomatics 1999;40:491–6.
27. 28. Patten SB, Williams JV. Self-reported allergies and their relationship to several Axis I disorders in a community sample. Int J Psychiatry Med 2007;37:11–22.
28. 29. Gauci M, King MG, Saxarra H, Tulloch BJ, Husband AJ. A Minnesota Multiphasic Personality Inventory profile of women with allergic rhinitis. Psychosom Med 1993;55:533–40.
29. 30. Addolorato G, Ancona C, Capristo E, et al. State and trait anxiety in women affected by allergic and vasomotor rhinitis. J Psychosom Res 1999;46:283–89.
30. 31. Derebery J, Meltzer E, Nathan RA, et al. Rhinitis symptoms and comorbidities in the United States: burden of rhinitis in America survey. Otolaryngol Head Neck Surg 2008;139:198–205.
31. 32. Huurre TM, Aro HM. Long-term psychosocial effects of persistent chronic illness. A follow-up study of Finnish adolescents aged 16 to 32 years. Eur Child Adolesc Psychiatry 2002;11:85–91.
32. 33. Bavbek S, Kumbasar H, Tu¤cu H, Misirligil Z. Psychological status of patients with seasonal and perennial allergic rhinitis. J Investig Allergol Clin Immunol 2002;12:204–10.
33. 34. Muluk NB, O¤uztürk O, Koç C, Ekici A. Minnesota Multiphasic Personality Inventory profile of patients with allergic rhinitis. J Otolaryngol 2003;32:198–202.
34. 35. Xi L, Zhang Y, Han D, Zhang L. Effect of asthma, aeroallergen category, and gender on the psychological status of patients with allergic rhinitis. J Investig Allergol Clin Immunol 2012;22:264–9.
35. 36. Annesi-Maesano I, Beyer A, Marmouz F, Mathelier-Fusade P, Vervloet D, Bauchau V. Do patients with skin allergies have higher levels of anxiety than patients with allergic respiratory diseases? Results of a large-scale cross-sectional study in a French population. Br J Dermatol 2006;154:1128–36.
36. 37. Stauder A, Kovacs M. Anxiety symptoms in allergic patients: identification and risk factors. Psychosom Med 2003;65:816–23.
37. 38. Bell IR, Jasnoski ML, Kagan J, King DS. Depression and allergies: survey of a nonclinical population. Psychother Psychosom 1991;55;1:24–31.
38. 39. Simons FE, Prenner BM, Finn A Jr; Desloratadine Study Group. Efficacy and safety of desloratadine in the treatment of perennial allergic rhinitis. J Allergy Clin Immunol 2003;111:617–22.
39. 40. Graif Y, Goldberg A, Tamir R, Vigiser D, Melamed S. Skin test results and self-reported symptom severity in allergic rhinitis: the role of psychological factors. Clin Exp Allergy 2006;36:1532–7.